Invesco Ltd. Alnylam Pharmaceuticals, Inc. Transaction History

Invesco Ltd.

$460 Billion
Q2 2024

A detailed history of Invesco Ltd. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 392,841 shares of ALNY stock, worth $105 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

392,841

Previous 178,313 120.31%

Holding current value

$105 Million

Previous $26.6 Million 258.23%

% of portfolio

0.02%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$143.31 - $247.0 $30.7 Million - $53 Million	214,528 Added 120.31%	392,841 $95.5 Million
Q1 2024 May 14, 2024	BUY	$146.51 - $198.2 $212,879 - $287,984	1,453 Added 0.82%	178,313 $26.6 Million
Q4 2023 Feb 12, 2024	SELL	$151.41 - $196.57 $6.01 Million - $7.81 Million	-39,709 Reduced 18.34%	176,860 $33.9 Million
Q3 2023 Nov 13, 2023	SELL	$170.77 - $211.65 $29.6 Million - $36.7 Million	-173,558 Reduced 44.49%	216,569 $38.4 Million
Q2 2023 Aug 11, 2023	BUY	$185.01 - $212.05 $4.21 Million - $4.82 Million	22,752 Added 6.19%	390,127 $74.1 Million
Q1 2023 May 12, 2023	SELL	$182.66 - $235.53 $55.2 Million - $71.2 Million	-302,474 Reduced 45.16%	367,375 $73.6 Million
Q4 2022 Feb 13, 2023	SELL	$185.53 - $241.31 $12.6 Million - $16.4 Million	-67,981 Reduced 9.21%	669,849 $159 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $78.8 Million - $132 Million	568,999 Added 337.02%	737,830 $148 Million
Q2 2022 Aug 15, 2022	SELL	$120.42 - $169.29 $96.3 Million - $135 Million	-799,924 Reduced 82.57%	168,831 $24.6 Million
Q1 2022 May 16, 2022	BUY	$127.18 - $173.91 $10 Million - $13.7 Million	78,665 Added 8.84%	968,755 $158 Million
Q4 2021 Feb 14, 2022	SELL	$159.56 - $209.29 $26.2 Million - $34.3 Million	-164,082 Reduced 15.57%	890,090 $151 Million
Q3 2021 Nov 15, 2021	BUY	$169.75 - $207.73 $8.87 Million - $10.9 Million	52,271 Added 5.22%	1,054,172 $199 Million
Q2 2021 Aug 17, 2021	SELL	$128.63 - $176.89 $27.6 Million - $37.9 Million	-214,202 Reduced 17.61%	1,001,901 $170 Million
Q1 2021 May 17, 2021	SELL	$126.83 - $175.69 $7.88 Million - $10.9 Million	-62,139 Reduced 4.86%	1,216,103 $172 Million
Q4 2020 Feb 16, 2021	BUY	$122.97 - $147.0 $22.6 Million - $27 Million	183,591 Added 16.77%	1,278,242 $166 Million
Q3 2020 Nov 16, 2020	SELL	$121.19 - $165.49 $3.64 Million - $4.97 Million	-30,044 Reduced 2.67%	1,094,651 $159 Million
Q2 2020 Aug 14, 2020	BUY	$104.21 - $156.44 $40.1 Million - $60.3 Million	385,249 Added 52.1%	1,124,695 $167 Million
Q1 2020 May 15, 2020	BUY	$93.12 - $133.99 $15 Million - $21.6 Million	161,316 Added 27.9%	739,446 $80.5 Million
Q4 2019 Feb 14, 2020	BUY	$74.51 - $124.23 $2.58 Million - $4.3 Million	34,648 Added 6.38%	578,130 $66.6 Million
Q3 2019 Nov 14, 2019	BUY	$70.9 - $87.82 $3.33 Million - $4.12 Million	46,934 Added 9.45%	543,482 $43.7 Million
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $19.1 Million - $26.8 Million	289,314 Added 139.61%	496,548 $36 Million
Q1 2019 May 15, 2019	BUY	$72.76 - $93.45 $13.8 Million - $17.7 Million	189,786 Added 1087.72%	207,234 $19.4 Million
Q4 2018 Feb 14, 2019	BUY	$62.67 - $88.33 $1.09 Million - $1.54 Million	17,448 New	17,448 $1.27 Million

Others Institutions Holding ALNY

# of Institutions

614

Shares Held

108M

Call Options Held

2.33M

Put Options Held

2.17M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $33B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account